Skip to main content
. 2022 Mar 11;2022(3):CD013130. doi: 10.1002/14651858.CD013130.pub2

Comparison 6. Thalidomide versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
6.1 Disease‐specific mortality 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected